EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+10.2%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$4.74B
AUM Growth
+$276M
(+6.2%)
Cap. Flow
-$6.68M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
17.82%
Holding
996
New
57
Increased
184
Reduced
143
Closed
49
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$10.4M |
| 2 |
Kinsale Capital Group
KNSL
|
$10.1M |
| 3 |
Array Technologies
ARRY
|
$8.23M |
| 4 |
NVIDIA
NVDA
|
$7.97M |
| 5 |
Apple
AAPL
|
$7.32M |
Top Sells
| 1 |
DQ
Daqo New Energy
DQ
|
$18.4M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$15.7M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$11.3M |
| 4 |
HEICO
HEI
|
$10.8M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$10.4M |
Sector Composition
| 1 | Technology | 28.76% |
| 2 | Healthcare | 20.98% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Boston Scientific
BSX
$159B
| $478K | 0.01% |
10,305
-18,850
| -65% | -$874K |
|
427
Zai Lab
ZLAB
$3.42B
| $463K | 0.01% |
15,100
| – | – |
|
428
McKesson
MCK
$85.5B
| $457K | 0.01% |
+1,218
| New | +$457K |
|
429
Hamilton Lane
HLNE
$6.41B
| $453K | 0.01% |
7,099
-366
| -5% | -$23.4K |
|
430
Afya
AFYA
$1.37B
| $453K | 0.01% |
28,191
| – | – |
|
431
Twist Bioscience
TWST
$1.55B
| $448K | 0.01% |
19,100
| – | – |
|
432
BioCryst Pharmaceuticals
BCRX
$1.74B
| $447K | 0.01% |
40,000
| – | – |
|
433
Ocular Therapeutix
OCUL
$2.37B
| $445K | 0.01% |
158,800
+63,000
| +66% | +$176K |
|
434
Krystal Biotech
KRYS
$4.35B
| $431K | 0.01% |
5,400
| – | – |
|
435
Devon Energy
DVN
$22.1B
| $427K | 0.01% |
7,000
-3,000
| -30% | -$183K |
|
436
Principal Financial Group
PFG
$17.8B
| $419K | 0.01% |
4,900
-1,800
| -27% | -$154K |
|
437
Revolution Medicines
RVMD
$7.57B
| $418K | 0.01% |
17,400
| – | – |
|
|
BCYC
438
Bicycle Therapeutics
BCYC
$496M
| $414K | 0.01% |
14,000
| – | – |
|
439
Veracyte
VCYT
$2.55B
| $410K | 0.01% |
17,000
| – | – |
|
440
Graphic Packaging
GPK
$6.38B
| $402K | 0.01% |
18,000
-20,900
| -54% | -$467K |
|
441
Maravai LifeSciences
MRVI
$363M
| $400K | 0.01% |
28,400
| – | – |
|
442
NIO
NIO
$13.4B
| $400K | 0.01% |
40,000
| – | – |
|
443
Pacira BioSciences
PCRX
$1.19B
| $382K | 0.01% |
9,800
| – | – |
|
444
Compañía de Minas Buenaventura
BVN
$5.08B
| $377K | 0.01% |
+50,000
| New | +$377K |
|
445
Fair Isaac
FICO
$36.8B
| $364K | 0.01% |
600
| – | – |
|
446
Pure Storage
PSTG
$25.9B
| $363K | 0.01% |
+13,800
| New | +$363K |
|
|
AUTL
447
Autolus Therapeutics
AUTL
$389M
| $353K | 0.01% |
195,000
+75,000
| +63% | +$136K |
|
448
Colliers International
CIGI
$8.43B
| $346K | 0.01% |
+3,900
| New | +$346K |
|
449
Relay Therapeutics
RLAY
$710M
| $342K | 0.01% |
23,100
| – | – |
|
450
Replimune Group
REPL
$494M
| $330K | 0.01% |
11,900
| – | – |
|